We are live on ! Find out more
BSX icon

Boston Scientific

855 hedge funds and large institutions have $58B invested in Boston Scientific in 2019 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 301 increasing their positions, 276 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more funds holding in top 10

Funds holding in top 10: 13 → 29 (+16)

64% more first-time investments, than exits

New positions opened: 95 | Existing positions closed: 58

11% more funds holding

Funds holding: 771 → 855 (+84)

9% more repeat investments, than reductions

Existing positions increased: 301 | Existing positions reduced: 276

6% more call options, than puts

Call options by funds: $188M | Put options by funds: $176M

0.19% less ownership

Funds ownership: 92.27% → 92.08% (-0.19%)

8% less capital inflows, than outflows

Capital inflows: $2.56B | Capital outflows: $2.78B

Holders
855
Holders Change
+84
Holders Change %
+10.89%
% of All Funds
16.8%
Holding in Top 10
29
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+123.08%
% of All Funds
0.57%
New
95
Increased
301
Reduced
276
Closed
58
Calls
$188​M
Puts
$176​M
Net Calls
+$11.4​M
Net Calls Change
-⁠$82.7​M

BSX Hedge Fund Activity: Q4 2019 in Review

855 of the 5,090 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2019, worth a combined $58B — up 11% from $52.3B a quarter earlier.

Buyers outnumbered sellers: 95 funds opened new BSX positions and 58 closed out — a net gain of 37 holders — while 301 added to existing stakes and 276 trimmed.

The largest buyer was Jennison Associates, adding an estimated $399M. The largest seller was Wellington Management Group, cutting an estimated $723M.

  • 855 institutional investors held Boston Scientific (BSX) as of Q4 2019, up from 771 in Q3 2019.
  • Funds reported $58B of Boston Scientific stock for Q4 2019, up 11% quarter-over-quarter.
  • 95 funds opened new Boston Scientific positions in Q4 2019 and 58 closed out, a net change of +37 holders.
  • The largest Boston Scientific buyer in Q4 2019 was Jennison Associates, an estimated $399M added.
  • The largest Boston Scientific seller in Q4 2019 was Wellington Management Group, an estimated $723M sold.

Based on aggregated 13F filings for Q4 2019.